ClinicalTrials.gg
Not yet recruitingNCT07870408Updated Oct 21, 2026

Correlation Between Soft Tissue Displacement and Functional Performance in Orthopedic Patients

An interventional study of Nordic Hamstring Exercise Training and Custom Foot Orthoses and Exercise Therapy in Hamstring Muscle Strain, Adult Acquired Flatfoot Deformity and Ulnar Collateral Ligament Sprain After Reconstruction, sponsored by National Taiwan University Hospital. Not yet recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Updated Oct 21, 2026Eligibility revisedInterventions changed+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The goal of this clinical trial is to investigate the correlations between dynamic soft tissue displacement, mechanical properties, and functional recovery across three studies: biceps femoris long head (BFlh) muscle injury, adult acquired flatfoot deformity (AAFD), and medial ulnar collateral ligament anterior bundle (mUCLAB) reconstruction. The main questions it aims to answer are:

  1. In athletes with BFlh injury who have returned to sport but remain limited in full participation, does an 8-week Nordic hamstring exercise (NHE) program alter BFlh displacement measured by ultrasound speckle tracking (UST) during maximal eccentric testing and improve eccentric strength?
  2. In adults with flexible AAFD/PCFD, does a 6-week intervention of conservative exercise and custom foot orthoses alter the dynamic mechanical behavior (longitudinal displacement and dynamic torsion tracked by UST) and mechanical properties (shear wave elastography, SWE) of the posterior tibial tendon (PTT)?
  3. In overhead athletes after mUCLAB reconstruction, does an 8-week blood flow restriction (BFR) training program targeting the forearm flexor-pronator mass reduce regional strain quantified by UST and alter the Young's modulus of the reconstructed graft under dynamic valgus stress?

Researchers will compare biomechanical and functional outcomes within participants before and after each intervention, as well as against comparison groups (athletes with full return-to-sport clearance or asymptomatic flatfoot adults), using UST algorithms and SWE. Depending on their allocated cohort, participants will:

Part 1 (Hamstring Muscle Injury):

  • Perform an 8-week progressive Nordic hamstring exercise (NHE) program (for the experimental group)
  • Undergo BFlh muscle stiffness assessment using SWE and power Doppler examination for intramuscular scar vascularity
  • Complete pain-free maximal isokinetic eccentric knee flexion tests and isometric contractions combined with UST and surface electromyography (sEMG) to measure muscle displacement, scar gap size, and peak torque
  • Complete hamstring flexibility testing (active knee extension test) and fill out the Functional Assessment Scale for Acute Hamstring Injuries (FASH)

Part 2 (Adult Acquired Flatfoot Deformity):

  • Receive 6 weeks of conservative intervention consisting of wearing custom-molded foot orthoses (for at least 85% of days) combined with progressive PTT eccentric training, short-foot exercises, and calf stretches
  • Undergo SWE to evaluate proximal and distal PTT shear wave velocity. Perform progressive isometric foot adduction on an isokinetic dynamometer with UST recording raw radiofrequency (RF) data to measure PTT longitudinal displacement and cross-sectional dynamic torsion
  • Complete clinical assessments at baseline, 6 weeks, and 12-week follow-up, including single-leg heel-rise tests, isokinetic strength, ankle range of motion, force-plate balance tests, 5-minute walk tests, and self-reported questionnaires (FFI-R, MSK-HQ)

Part 3 (Elbow Ligament Reconstruction Cohort):

  • Participate in an 8-week progressive isokinetic strength training program for the forearm flexor-pronator mass combined with blood flow restriction, alongside grip training
  • Undergo dynamic elbow valgus stress testing at 5 N·m torque on an isokinetic dynamometer synchronized with UST and SWE to evaluate regional strain and Young's modulus of the reconstructed mUCLAB
  • Complete upper-extremity evaluations before and after training, including shoulder-elbow range of motion, isometric muscle strength using hand-held dynamometry, countermovement push-up (CMPU) power tests on force plates, and the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire
02

Conditions studied

  • Hamstring Muscle Strain
  • Adult Acquired Flatfoot Deformity
  • Ulnar Collateral Ligament Sprain After Reconstruction

Browse trials for

Keywords

  • Soft tissue
  • Rehabilitation
  • Physical therapy
  • Ultrasound speckle tracking
03

In context

Flatfoot

171 studies on the registry are indexed under Flatfoot; 42 are open to participants now.

This study's planned enrollment of 80 is above the median of 37 across 124 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,608 studies on the registry; 573 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Part 1

Inclusion Criteria:

  • Aged between 18 and 40 years
  • Participated in regular physical exercise for at least 2.5 hours per week
  • Experimental group: Sustained a unilateral hamstring muscle injury diagnosed as a muscle strain within the past 6 months, have returned to the team, but currently remain unable to fully participate in training or competition at maximal intensity
  • Control group: Sustained a unilateral hamstring muscle injury within the past 6 months, have achieved full return to sport, and are fully able to participate in maximal-intensity training and competition
  • Palpation assessment confirms tenderness isolated to the unilateral biceps femoris long head

Exclusion Criteria:

  • Palpable distinct defect or gap within the injured biceps femoris long head resembling a severe (grade III) muscle tear
  • Known systemic diseases that may alter soft tissue composition and mechanical properties
  • Other musculoskeletal injuries of the lower extremity within the past 6 months (e.g., fractures)
  • History of surgery in the lower extremities
  • Any lower extremity orthopedic conditions (e.g., knee osteoarthritis, patellofemoral pain)

Part 2

Inclusion Criteria:

  • Aged between 18 and 80 years
  • Diagnosed with functional or flexible flatfoot and recommended for conservative treatment by a physician
  • Six-Item Foot Posture Index (FPI-6) score >= 6, or a navicular drop test (NDT) > 9 mm.

Exclusion Criteria:

  • Recommended by a physician to undergo surgical treatment
  • Structural or rigid flatfoot
  • Posterior tibial tendon rupture or tendinopathy (including acute tenosynovitis or chronic tendinosis)
  • Presence of chronic ankle instability, or residual symptoms resulting from traumatic foot ligament tear
  • Other lower-extremity neuromusculoskeletal disorders, trauma with residual symptoms, or history of surgical intervention
  • Any physical condition that could interfere with the study procedures

Part 3

Inclusion Criteria:

  • Overhead throwing athletes aged between 18 and 35 years
  • History of unilateral anterior bundle medial ulnar collateral ligament (mUCLAB) reconstruction
  • Have returned to sports training and competition following reconstruction surgery

Exclusion Criteria:

  • Known systemic diseases that alter soft tissue composition and mechanical properties (e.g., ankylosing spondylitis, rheumatoid arthritis, amyloidosis, type 1 diabetes)
  • History of two or more mUCLAB reconstruction surgeries (revision reconstructions)
  • History of central or peripheral cardiovascular diseases
  • Any other physical condition that interferes with daily sports training and competition
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Athletes with BFlh Strain with Limited Return

    Athletes within 6 months of a unilateral biceps femoris long head (BFlh) muscle injury who have returned to the team but cannot fully participate in high-intensity training or competition. Participants complete an 8-week progressive Nordic hamstring exercise program (twice weekly, progressing from 3 sets of 6 to 3 sets of 12 repetitions) to evaluate changes in muscle displacement and eccentric knee flexor strength.

    Behavioral: Nordic Hamstring Exercise Training

  • Experimental
    Adults with Symptomatic Adult Acquired Flatfoot Deformity

    Adults aged 18-80 years diagnosed with symptomatic flexible flatfoot (FPI-6 score \>= 6 or navicular drop \> 9 mm). Participants undergo 6 weeks of conservative therapy consisting of daily custom foot orthoses, progressive posterior tibial tendon eccentric training (twice weekly), daily short-foot exercises, and calf stretching, followed by evaluation at baseline, week 6, and week 12 follow-up.

    Behavioral: Custom Foot Orthoses and Exercise Therapy

  • Experimental
    Overhead Athletes with Post-mUCL Reconstruction

    Overhead athletes aged 18-35 years who have undergone unilateral medial ulnar collateral ligament anterior bundle (mUCLAB) reconstruction and returned to training or competition. Participants complete an 8-week progressive isokinetic strength training program targeting the forearm flexor-pronator mass under blood flow restriction twice weekly.

    Other: Forearm Blood Flow Restriction Training

Interventions

  • BehavioralNordic Hamstring Exercise Training

    An 8-week progressive Nordic hamstring curl exercise protocol performed twice weekly. Following initial technique instruction, participants perform progressive eccentric hamstring curls starting from 3 sets of 6 repetitions in weeks 1-2 and progressing to 3 sets of 12 repetitions in weeks 7-8.

  • BehavioralCustom Foot Orthoses and Exercise Therapy

    A 6-week conservative program consisting of: (1) Wearing custom-molded foot orthoses daily during ambulatory activities; (2) Progressive eccentric posterior tibial tendon strengthening on an isokinetic dynamometer (twice a week, 3 sets of 15 repetitions); (3) Progressive short-foot exercises (30-40 repetitions daily); and (4) Gastrocnemius and soleus stretching.

  • OtherForearm Blood Flow Restriction Training

    An 8-week progressive isokinetic strength training program targeting the forearm flexor-pronator muscles (pronator teres, flexor carpi ulnaris, brachialis) and handgrip, performed twice weekly. Exercises are performed under pneumatic blood flow restriction set at 70% limb occlusion pressure (LOP) of the brachial artery, at 40-60% of maximal voluntary isometric contraction (4 sets of 20 repetitions per muscle group).

06

What researchers measure

Primary outcomes

  1. Longitudinal Muscle Displacement of the Biceps Femoris Long Head (Arm 1)

    Longitudinal muscle displacement in millimeters of the middle biceps femoris long head (BFlh) tracked using ultrasound speckle tracking during a 20°/s maximal pain-free isokinetic eccentric knee flexion task.

    Time frame: Baseline and Week 8 post-intervention

  2. Posterior Tibial Tendon Dynamic Torsion, Tendon Displacement, and Shear Wave Velocity (Arm 2)

    PTT dynamic torsion and displacement quantified using cross-sectional ultrasound speckle tracking during maximal isometric foot adduction, and tendon mechanical properties evaluated as mean shear wave velocity using shear wave elastography at proximal and distal tibialis posterior tendon.

    Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)

  3. Regional Strain of the Reconstructed mUCLAB Graft (Arm 3)

    Regional engineering strain along the longitudinal axis of the reconstructed medial ulnar collateral ligament anterior bundle (mUCLAB) across proximal, middle, and distal regions, quantified using ultrasound speckle tracking under a standardized 5 N·m dynamic valgus torque.

    Time frame: Baseline and Week 8 post-intervention

Secondary outcomes

  1. Eccentric Knee Flexor Peak Torque (Arm 1)

    Maximal eccentric knee flexor peak torque (N·m) evaluated at 20°/s isokinetic velocity using an isokinetic dynamometer (Biodex Medical Systems, NY, USA) across a range of 90° to 0° knee flexion.

    Time frame: Baseline and Week 8 post-intervention

  2. Functional Assessment Scale for Acute Hamstring Injuries (FASH) Score (Arm 1)

    Self-reported hamstring injury symptoms and physical function assessed using the FASH questionnaire. The score ranges from 0 to 100, where higher scores indicate superior hamstring function and less severity of symptoms.

    Time frame: Baseline and Week 8 post-intervention

  3. Long Head of Biceps Femoris Muscle Shear Wave Velocity (Arm 1)

    Resting muscle stiffness quantified as shear wave velocity (m/s) at the suspected BFlh injury site and adjacent regions (1 cm proximal and distal) using shear wave elastography with a curved transducer.

    Time frame: Baseline and Week 8 post-intervention

  4. Intramuscular Power Doppler Vascularity Grade (Arm 1)

    Vascularity around the suspected BFlh injury site evaluated using power Doppler ultrasonography on a 4-point ordinal scale: Grade 0 (no flow or 1 color pixel), Grade 1 (2-3 color pixels or 1 vessel), Grade 2 (2-3 vessels), and Grade 3 (\>3 vessels).

    Time frame: Baseline and Week 8 post-intervention

  5. Intramuscular Scar Gap Size During Isometric Contraction (Arm 1)

    Measurement of the presence and gap size (mm) around the intramuscular scar tissue visualized in the longitudinal view under dynamic B-mode ultrasound during maximal voluntary isometric knee flexion at 30°.

    Time frame: Baseline and Week 8 post-intervention

  6. Hamstring Flexibility (Arm 1)

    Hamstring flexibility evaluated via the active knee extension test in a supine 90-90 hip-knee position, recorded as the final achieved knee extension angle (in degrees, °) measured with a goniometer.

    Time frame: Baseline and Week 8 post-intervention

  7. Revised Foot Function Index (FFI-R) (Arm 2)

    Patient-reported foot symptoms, pain, disability, and activity limitation evaluated via the Revised Foot Function Index (FFI-R), scored from 0 to 100 with higher scores reflecting greater impairment.

    Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)

  8. Musculoskeletal Health Questionnaire (MSK-HQ) Score (Arm 2)

    Overall musculoskeletal health status and quality of life assessed via the MSK-HQ. The total score ranges from 0 to 56, with higher scores representing better musculoskeletal health.

    Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)

  9. Visual Analog Scale (Arm 2)

    Patient self-reported foot pain intensity measured on a 100-mm Visual Analog Scale (VAS), where 0 mm indicates no pain and 100 mm indicates worst imaginable pain.

    Time frame: Baseline, each treatment session before/after, Week 6, and Week 12 (follow-up)

  10. Single-Leg Heel-Rise Test (Arm 2)

    Functional performance of the posterior tibial muscle evaluated via the single-leg heel-rise test, documenting heel elevation height (cm) and the presence of heel inversion.

    Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)

  11. Maximal Voluntary Isometric Foot Inversion Torque (Arm 2)

    Maximal voluntary isometric foot inversion peak torque (N·m) measured using an isokinetic dynamometer (Biodex Medical Systems, NY, USA) with simultaneous electromyography monitoring to ensure isolation of the tibialis posterior.

    Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)

  12. Five-Minute Walk Test (Arm 2)

    Functional walking capacity evaluated as the total distance walked (in meters) within 5 minutes.

    Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)

  13. Y-Balance Test (Arm 2)

    Dynamic standing balance evaluated via the Y-balance test with the stance leg, recording foot excursion (in cm) during movement of the reach leg.

    Time frame: Baseline, Week 6 (post-intervention), and Week 12 (follow-up)

  14. Countermovement Push-Up (CMPU) Maximal Vertical Force (Arm 3)

    Upper-extremity explosive strength and power assessed as maximal vertical ground reaction force (in Newtons) recorded on a portable force plate during the CMPU test.

    Time frame: Baseline and Week 8 post-intervention

  15. Disabilities of the Arm, Shoulder, and Hand (DASH) Score (Arm 3)

    Subjective upper-extremity functional recovery and disability assessed using the Taiwan version of the DASH questionnaire, scored from 0 to 100 (higher scores indicate greater disability and symptom severity).

    Time frame: Baseline and Week 8 post-intervention

  16. Regional Young's Modulus of Reconstructed mUCLAB (Arm 3)

    Tissue elasticity and stiffness (in kPa) of the reconstructed mUCLAB measured at the proximal, middle, and distal regions using shear wave elastography.

    Time frame: Baseline and Week 8 post-intervention

  17. Shoulder and Elbow Maximal Voluntary Isometric Muscle Strength (Arm 3)

    Maximal voluntary isometric contraction strength (in Newtons or kilograms) of the shoulder and elbow muscle groups measured using a hand-held dynamometer (microFET®2, Hoogan Health Industries, West Jordan, UT, USA).

    Time frame: Baseline and Week 8 post-intervention

  18. Shoulder and Elbow Active Range of Motion (Arm 3)

    Active range of motion (in degrees, °) of the shoulder (flexion, internal/external rotation) and elbow (flexion, extension, pronation, supination) measured using a standard universal goniometer.

    Time frame: Baseline and Week 8 post-intervention

07

Study locations

1 site
  • School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
    Taipei City, Taipei 10055, Taiwan
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jul 2028, 20 months later.

Of 89 non-industry interventional studies with no phase under Flatfoot, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 15. This study's planned 20 months is above that.

Counting every sponsor, half of 89 studies reached it within 7 months; a quarter within 2 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2026
First posted
Oct 13, 2026
StartEst.
Nov 2026
Primary completionEst.
Jul 2028
CompletionEst.
Jul 2028
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
eligibility and interventions
Registered
First appeared on the registry
Oct 13, 2026
Show all 2 updates
  1. Oct 21, 2026
    Eligibility Criteria revised
    Interventions Arms or interventions changed
    + 6 other changes: index terms, description, conditions, design details, secondary outcomes and contact details
  2. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07870408
Responsible party
Sponsor
First posted
Oct 13, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jul 2028 (estimated)
Completion
Jul 2028 (estimated)
Last update
Oct 21, 2026

Study contacts

Hsing-Kuo Wang, DPT, PhD
Contact
hkwang@ntu.edu.tw
+886-2-33668154
Hsing-Kuo Wang, DPT, PhD
study chair · School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion